Quick Answer
CORCEPT THERAPEUTICS INC reported Stockholders Equity of $647.80 million for fiscal year 2025.
CORCEPT THERAPEUTICS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $647.80M | -4.7% |
| 2024 | $679.59M | +34.1% |
| 2023 | $506.70M | +1.0% |
| 2022 | $501.84M | +33.5% |
| 2021 | $375.81M | -28.2% |
| 2020 | $523.34M | +41.0% |
| 2019 | $371.18M | +34.5% |
| 2018 | $275.88M | +44.5% |
| 2017 | $190.97M | +361.5% |
| 2016 | $41.38M | +123.7% |
| 2015 | $18.50M | +646.0% |
| 2014 | -$3.39M | -116.1% |
| 2013 | $21.02M | -66.0% |
| 2012 | $61.78M | +77.5% |
| 2011 | $34.81M | +63.8% |
| 2010 | $21.24M | -3.8% |
| 2009 | $22.09M | +30.7% |
| 2008 | $16.91M | +14.7% |
| 2007 | $14.73M | +131.7% |
| 2006 | $6.36M | -76.1% |
| 2005 | $26.59M | -42.1% |
| 2004 | $45.95M | +246.0% |
| 2003 | -$31.47M | -43.5% |
| 2002 | -$21.94M | -191.0% |
| 2001 | -$7.54M | -277.1% |
| 2000 | -$2.00M | -719.3% |
| 1999 | -$244.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $631.90M | -1.1% | -0.6% |
| June 30, 2025 | $635.79M | +6.6% | -7.0% |
| March 31, 2025 | $683.28M | +24.7% | +0.5% |
| December 31, 2024 | $679.59M | +34.1% | +6.4% |
| September 30, 2024 | $638.84M | +38.4% | +7.1% |
| June 30, 2024 | $596.24M | +41.4% | +8.8% |
| March 31, 2024 | $547.86M | +3.5% | +8.1% |
| December 31, 2023 | $506.70M | +1.0% | +9.8% |
- CORCEPT THERAPEUTICS INC showed a decrease of -4.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 1999–2025 period, CORCEPT THERAPEUTICS INC’s stockholders equity has grown by 265593.9% (from -$244.0 thousand to $647.80 million).
- The most recent figure is from CORCEPT THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: